Jyong BiotechMENS
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 8 institutions reported holding Jyong Biotech Ltd. (MENS) in their 13F filings, up 6 from Q2 2025. 6 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($2.1M), HRT Financial LP ($819K) and Millennium Management ($512K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Jyong Biotech Ltd.
- CUSIP
- G83116106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.8M |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 71,989 shares bought and 60,432 shares sold, net +11,557 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Geode Capital Management, LLC | 0.00% | New | 53,844 | $2.1M |
| HRT Financial LP | 0.00% | Reduce -9.2% | 20,819 | $819K |
| Millennium Management | 0.00% | New | 13,013 | $512K |
| Citadel Advisors | 0.00% | Reduce -82.2% | 12,641 | $498K |
| Morgan Stanley | 0.00% | New | 2,871 | $113K |
| BNP Paribas Financial Markets | 0.00% | New | 1,698 | $67K |
| UBS Group AG | 0.00% | New | 537 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 26 | $1K |
"% of holder's portfolio" is MENS's weight in each manager's 13F, not the share of Jyong Biotech Ltd. the manager owns.